Skip to content

Oropharyngeal space in videolaryngoscopy: a randomised crossover trial measuring remaining space adjacent to the video laryngoscope blade.

Oropharyngeal space in videolaryngoscopy: a randomised crossover trial measuring remaining space adjacent to the video laryngoscope blade. - Oropharyngeal space in videolaryngoscopy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37542
Enrollment
450
Registered
2012-04-18
Start date
2012-05-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phalatopharyngeal distance

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ASA I, II and III patients, aged > 18 years, who will undergo an elective surgical procedure under general anaesthesia.

Exclusion criteria

Exclusion criteria: ASA IV patients undergoing emergence surgery with pre-operatively expected difficult airway, bad or fragile dentition, dental crowns and/or fixed partial denture

Design outcomes

Primary

MeasureTime frame
Our primary parameter is: Measuring the space on the right side of the videolaryngoscope blade and the palatopharyngeal wall in a cohort of ASA I-III patients with a normal mouth opening (Mallampati I, II and III).

Secondary

MeasureTime frame
Investigating how this space differs from the space that remains on the right side of the blade of the classic Macintosh laryngoscope and the palatopharyngeal wall in the same cohort of patients. Comparing the difference in remaining space between the different videolaryngoscopes. Registering difficulty of intubation (Cormack-Lehane score), successful intubation, use of rigid stylet, number of attempts, time until picking up endotracheal tube, epiglottic downfolding and any complication during intubation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)